Expert Q&A: Full Approval for Alzheimer’s Blood Tests Not Far Off
Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.
Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.
Alison Green, PhD, head of laboratory sciences at Scottish Brain Sciences, discusses recent developments in AD blood tests
A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?